Skip to content

Clinical trials

Phase 2 Major Depressive Disorder trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2 Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20152
20172
20181
20191
20201
20212
20221
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Mental Health Center6
First Affiliated Hospital of Chongqing Medical University2
Beijing Greatway Pharmaceutical Technology Co.,Ltd.1
Boehringer Ingelheim1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
Chengdu Kanghong Pharmaceutical Group Co., Ltd.1
Chengdu University of Traditional Chinese Medicine1
Jiangsu Nhwa Pharmaceutical Co., Ltd.1
Lingjiang Li1
Sichuan Purity Pharmaceutical Technology Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder18
Depressive Disorder1
Depressive Disorder, Treatment-Resistant1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.